Murthy, R, Loi, S, Okines, A, Paplomata, E, Hamilton, E, Hurvitz, S, Lin, N, Borges, V, Abramson, V G, Anders, C, Bedard, P L, Oliveira, M, Jakobsen, E, Bachelot, T, Shachar, S S, Mueller, V, Braga, S, Duhoux, F P, Greil, R, Cameron, D, Carey, L, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & Winer, E 2020, ' Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB) ', Cancer research, vol. 80, no. Suppl. 4 . https://doi.org/10.1158/1538-7445.SABCS19-GS1-01